After a heart attack, cardiologists can reopen blocked vessels and restore blood flow, but the muscle cells that died will never be replaced.

Dyne Therapeutics (NasdaqGS:DYN) has initiated the Phase 3 Harmonia trial of DYNE-101 in myotonic dystrophy type 1, following alignment with the FDA on the study design. The Harmonia trial is a ...

For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...

After a heart attack, cardiologists can reopen blocked vessels and restore blood flow, but the muscle cells that died will never be replaced "The heart is one of the organs with the least ability to ...

Volkswagen Group has begun series production of the ID.UNYX 08, its first fully connected all-electric full-size SUV designed specifically for the Chinese market. The vehicle is being produced at ...

Colas Rail UK has been awarded a five-year contract by Network Rail worth around €40 million to operate and maintain a fleet of eight Mobile Maintenance Trains used across Britain’s rail network.